Background: Venous thromboembolism (VTE) is a life-threatening vascular event with
environmental and genetic determinants. Recent VTE genome-wide association studies (GWAS) …

Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious
short- and long-term complications. In clinical practice, there is a need for improved plasma …

Host genetic variants influence the susceptibility and severity of several infectious diseases,
and the discovery of genetic associations with coronavirus disease 2019 (COVID-19) …

Platelets are anucleated cells produced by megakaryocytes, from which they inherit all the
components necessary to carry their functions. They circulate in blood vessels where they …

Genetic risk score (GRS) analysis is a popular approach to derive individual risk prediction
models for complex diseases. In venous thrombosis (VT), such type of analysis shall integrate …

Motivation MicroRNAs (miRNAs) are small RNA molecules (∼22 nucleotide long) involved
in post-transcriptional gene regulation. Advances in high-throughput sequencing …

Background Hypertriglyceridemia is an independent risk factor for major adverse
cardiovascular events, though the mechanisms linking triglycerides and platelet function with …

Depression is an independent risk factor of cardiovascular disease morbidity. Serotonin is a
key neurotransmitter in depressive pathology, contained within platelets, and is a weak …

Background Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the
only pharmacologic intervention available in the ischemic stroke acute phase. This treatment …

Platelets play a key role in thrombosis and hemostasis. Platelet count (PLT) and mean
platelet volume (MPV) are highly heritable quantitative traits, with hundreds of genetic signals …